Peptide & Compound Guide
At a glance
| Compound | MOTS-C |
|---|---|
| Type | Mitochondrial-derived peptide |
| U.S. regulatory context | Investigational; not FDA approved |
| Evidence level | Preclinical with emerging human research |
| Research area | Metabolism, mitochondrial signaling, exercise and aging research |
What is MOTS-C?
MOTS-C is a mitochondrial-derived peptide investigated for its role in cellular stress responses and metabolic regulation. It is of interest in longevity research because mitochondrial biology is closely tied to metabolism and aging.
What does the research examine?
Most mechanistic understanding comes from laboratory and animal studies, with a smaller human research base. Human therapeutic claims remain premature without larger controlled trials.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
MOTS-C should be described as a research topic rather than an established anti-aging treatment.
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.